Hong Ki Min Selected Research

Hong Ki Min Research Topics

Disease

15	Rheumatoid Arthritis 11/2023 - 01/2016
8	Arthritis (Polyarthritis) 04/2023 - 01/2015
6	Ankylosing Spondylitis 01/2023 - 11/2021
5	Axial Spondyloarthritis 01/2023 - 04/2019
4	Experimental Arthritis 04/2023 - 01/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 08/2007
3	Inflammation (Inflammations) 01/2023 - 12/2019
3	Dyslipidemias (Dyslipidemia) 08/2021 - 08/2007
2	Type 2 Diabetes Mellitus (MODY) 11/2021 - 10/2020
2	Atherosclerosis 08/2021 - 02/2020
2	Osteoarthritis 01/2021 - 01/2020
2	Hyperuricemia 11/2020 - 07/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 08/2007
1	Herpes Zoster 05/2023
1	Necrosis 01/2023
1	Dysbiosis 01/2023
1	Venous Thromboembolism 01/2023
1	Stroke (Strokes) 01/2023
1	Myocardial Infarction 01/2023
1	Thromboembolism 01/2023
1	Neoplasms (Cancer) 01/2023
1	Psoriatic Arthritis 11/2022
1	Spondylitis 01/2022
1	Alveolar Bone Loss 01/2022
1	Amyloidosis 01/2022
1	Periodontitis 01/2022
1	Bone Resorption 01/2022
1	Gout 08/2021
1	Gouty Arthritis 11/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2020
1	Obesity 10/2020
1	digital ulcers 01/2020
1	Dermatomyositis (Dermatopolymyositis) 01/2020
1	Orbital Pseudotumor 01/2019
1	Thyroid Diseases (Thyroid Disease) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Leukocytosis (Pleocytosis) 07/2015
1	Hypersensitivity (Allergy) 07/2015

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 11/2022 - 01/2015
4	InterleukinsIBA 11/2023 - 01/2020
4	Therapeutic UsesIBA 11/2022 - 01/2015
3	Tumor Necrosis Factor InhibitorsIBA 01/2023 - 12/2021
3	Antirheumatic Agents (DMARD)IBA 11/2022 - 08/2021
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
3	Uric Acid (Urate)IBA 08/2021 - 07/2015
3	LipidsIBA 08/2021 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 11/2023 - 01/2021
2	Interleukin-18 (Interleukin 18)IBA 11/2023 - 01/2021
2	Janus Kinase InhibitorsIBA 05/2023 - 01/2023
2	secukinumabIBA 01/2023 - 12/2021
2	Interleukin-22 (IL-22)IBA 12/2021 - 01/2020
2	Metformin (Glucophage)FDA LinkGeneric 11/2021 - 10/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 08/2007
1	interleukin-18 binding proteinIBA 11/2023
1	Tyrosine Kinase InhibitorsIBA 04/2023
1	Dasatinib (BMS 354825)FDA Link 04/2023
1	Collagen Type II (Type II Collagen)IBA 04/2023
1	CollagenIBA 04/2023
1	16S Ribosomal RNAIBA 01/2023
1	Butyrates (Butyrate)IBA 01/2023
1	omega-Chloroacetophenone (Mace)IBA 01/2023
1	curdlanIBA 01/2023
1	ametantrone (HAQ)IBA 10/2022
1	amsonic acid (DAS)IBA 10/2022
1	InterferonsIBA 05/2022
1	Prealbumin (Transthyretin)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	VitronectinIBA 01/2022
1	C-Reactive ProteinIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Tartrate-Resistant Acid PhosphataseIBA 12/2021
1	oxidized low density lipoproteinIBA 12/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2021
1	HLA-B27 Antigen (HLA B27 Antigen)IBA 11/2021
1	CalciumIBA 08/2021
1	tocilizumab (atlizumab)FDA Link 08/2021
1	Abatacept (Orencia)FDA Link 08/2021
1	TocotrienolsIBA 01/2021
1	fibroblast growth factor 21IBA 10/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2020
1	Sirolimus (Rapamycin)FDA Link 10/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2020
1	LigandsIBA 01/2020
1	Endothelins (Endothelin)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	Rituximab (Mabthera)FDA Link 12/2019
1	ChemokinesIBA 12/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016
1	Immunoglobulin Fc FragmentsIBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	HLA-B Antigens (HLA-B)IBA 07/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2015

Therapy/Procedure

5	Therapeutics 08/2021 - 01/2013
1	Ligation 01/2022
1	Ambulatory Care (Outpatient Care) 08/2021